To examine the role of glutamatergic signaling in the function of pancreatic islets, we have characterized a high affinity glutamate/aspartate uptake system in this tissue. The islet [3 H]glutamate uptake activity was Na ؉ -dependent, and it was blocked by L-trans-pyrrolidine-2,4-dicarboxylic acid, a blocker of neuronal and glial glutamate transporters. Islet glutamate transport activity exhibited a V max of 8.48 ؎ 1.47 fmol/min/islet (n ؍ 4), which corresponds to 102.2 ؎ 17.7 pmol/min/mg islet protein. The apparent K m of islet glutamate transport activity depended on the glucose concentration used in the assay. In the presence of glucose concentrations that do not stimulate insulin secretion (2.8 mM), the apparent K m was 34.7 ؎ 7.8 M (n ؍ 3). However, in high glucose (16.7 mM) the apparent K m increased to 112.7 ؎ 16.5 M (n ؍ 3) with little or no change in V max . Like most known plasma membrane glutamate transporters, islet glutamate transporters also transported D-aspartate. Anti-Daspartate immunoreactivity showed that the islet glutamate/aspartate transport activity was localized to the non- cell islet mantle. In perifusion experiments with isolated islets in the absence of exogenous amino acids, L-trans-pyrrolidine-2,4-dicarboxylic acid in the presence of 8.3 mM glucose potentiated insulin secretion 23.3 ؎ 2.3% (n ؍ 3) compared with 8.3 mM glucose alone. This effect was abolished in the presence of the ␣-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione. Furthermore, 6-cyano-7-nitroquinoxaline-2,3-dione alone inhibited glucose-stimulated insulin secretion in isolated islets by 15.9 ؎ 5.9% (n ؍ 3). Taken together these data suggest that a high affinity glutamate transport system exists in pancreatic islets and that this system contributes to a glutamatergic signaling pathway that can modulate glucose-inducible insulin secretion.Although the role of glutamate as a signaling molecule is well established in the central nervous system, a similar role in the periphery has only recently been suggested. We (1) and others (2) have detected functional glutamate receptors in the pancreatic islets of Langerhans. These miniature organs, found dispersed throughout the exocrine pancreas, are composed of four major cell types as follows: the insulin-secreting  cell, the glucagon-secreting ␣ cell, the pancreatic polypeptide-secreting PP cell, and the somatostatin-secreting ␦ cell. The electrically excitable  cells are stimulated to secrete insulin in response to changes in serum glucose concentrations. Secretion of insulin, and the three other major peptide hormones found in islets, is also believed to be affected by other metabolic and neuronal signals (reviewed in Refs. 3 and 4). Bertrand et al. (5,6) have shown that ␣-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) 1 receptor agonists can potentiate both insulin and glucagon secretion from a perfused pancreas preparation and that oral or intravenous glutamate can increase insulin secretio...